They concluded that ACC and insulin bolus calculation are effective, low-cost methods for lowering HbA1c and glycemic variability in people with T2DM who have poor glycemic control despite basal-bolus insulin treatment [35]. Here, INS is linked to type 2 diabetes mellitus.